Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Share-based Compensation (IS)Shares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

MediWound (MDWD) Interest & Investment Income (2016 - 2025)

MediWound has reported Interest & Investment Income over the past 13 years, most recently at $5.4 million for Q4 2025.

  • For Q4 2025, Interest & Investment Income rose 1068.9% year-over-year to $5.4 million; the TTM value through Dec 2025 reached $4.9 million, up 562.93%, while the annual FY2025 figure was $4.0 million, 96.14% up from the prior year.
  • Interest & Investment Income for Q4 2025 was $5.4 million at MediWound, up from -$399000.0 in the prior quarter.
  • Over five years, Interest & Investment Income peaked at $5.8 million in Q2 2023 and troughed at -$836000.0 in Q4 2023.
  • A 5-year average of $395105.3 and a median of -$246000.0 in 2023 define the central range for Interest & Investment Income.
  • On a YoY basis, Interest & Investment Income climbed as much as 52881.82% in 2023 and fell as far as 502.06% in 2023.
  • Year by year, Interest & Investment Income stood at -$635000.0 in 2021, then soared by 35.75% to -$408000.0 in 2022, then crashed by 104.9% to -$836000.0 in 2023, then skyrocketed by 33.85% to -$553000.0 in 2024, then skyrocketed by 1068.9% to $5.4 million in 2025.
  • Business Quant data shows Interest & Investment Income for MDWD at $5.4 million in Q4 2025, -$399000.0 in Q3 2025, and $429000.0 in Q2 2025.